The key is managing expectations: these are supportive tools, not pharmaceutical replacements
Financial supporters for this study had no role in study design, data collection, analysis, interpretation, writing, or publication of this work
STCube is nearing full enrollment in colorectal cancer and is preparing to initiate dosing in NSCLC
It varies among individuals and some patients may observe significant weight loss while others may get little or no clinical benefits
Those monitoring long-term results can review how long to stay on semaglutide for weight loss for guidance on treatment duration, and how to maintain weight loss after tirzepatide for strategies that translate across GLP-1 medications
Get Personalized Care from Healthons Medical Team As regulatory oversight increases, selecting a provider that prioritizes compliance and patient safety is critical